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Previous images show the 2D dose maps obtained with the GEM 
detector in 64 seconds. On the right there is the map for a 2,4 x 2,4 
cm X-rays irradiation field, on the left the one for a 4,0 x 4,0 cm X-
rays irradiation field. 
Conclusions: Our detector could represent significant improvement 
compared to measurement systems used until today. The results 
confirm its potentialities especially in terms of spatial resolution, 
acquisition time and linearity.  
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Purpose/Objective: Two-dimensional (2D) array detector has finite 
resolution due to its detector size and spacing. Dosimetric verification 
of small targets planned with IMRT is difficult because of the limited 
resolution as only a limited number of pixels handling the fluence. In 
addition, the overall inaccuracy due to the interpolation of signals will 
be higher. However, if the small field IMRT is verified at extended 
source to surface distance (SSD), fluence can be handled by the large 
area of the array and hence the more number of detectors due to 
inverse square law. Therefore, the purpose of the present study is to 
evaluate the response of 2D-detector array at extended SSDs for pre-
treatment verification of small targets. 
Materials and Methods: Four previously treated patients were 
studied. In planning CT slices, planning target volume (PTV) and organ 
at risk (OAR) were contoured. IMRT (sliding window) plans were 
generated in Eclipse (Varian Medical Systems, Palo Alto, CA, USA) 
treatment planning system (TPS) for Varian CL2300C/D linear 
accelerator using 5-7 fields of 6MV photon beam. For each patient, 
four verification plans were generated at 95cm, 100cm, 105cm and 
110cm SSD by keeping I’matriXX at 5cm depth. The planned fluence 
was then transferred to previously scanned I’matriXX (IBADosimetry, 
Scanditronix Wellhofer, Germany) and solid water slab assembly and 
doses were calculated. The dose planes measured with I’matriXX were 
compared with TPS calculated dose planes at corresponding SSD in 
OmniPro-IMRT software using 2D gamma (γ) index analysis. For gamma 
index analysis, 3% dose difference and 3mm distance to agreement 
criteria (3%/3mm) was used. Three parameters i.e. gamma maximum 
(γmax.), gamma average (γavg.)and percentage of pixels passing gamma 
value up to 1 (γ% ≤1) were noted. 
Results: 
Results are summarized in table-1. 
 
Table-1 shows the γ index analysis results for four patients 
 
 
 Patient-1 Patient-2 
SSD (cm) 95 100 105 110 95 100 105 110 
γ% ≤1 99.73 99.92 99.98 99.97 99.84 99.93 99.85 99.94 
γmax. 1.57 1.25 1.14 1.18 1.47 1.33 1.42 1.36 
γavg. 0.07 0.07 0.08 0.09 0.03 0.03 0.04 0.04 
 Patient-3 Patient-4 
SSD (cm) 95 100 105 110 95 100 105 110 
γ%≤1 99.25 99.63 99.48 99.58 99.55 99.78 99.90 99.87 
γmax. 1.68 1.51 1.61 1.73 1.95 1.77 1.37 1.48 
γavg. 0.08 0.07 0.08 0.07 0.05 0.05 0.05 0.06 
 
Figure-1 shows the increase in measurement area with increase in SSD 
from 95-110cm 
 
 
Conclusions: The verification of small IMRT fields showed increased 
gamma pass rate when measured at extended SSDs compared to the 
verification at normal measurement distance. This may be attributed 
to the involvement of increased number pixel chambers at larger SSD 
which increased the resolution and accuracy of measured dose-plane.  
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Purpose/Objective: To investigate the properties and efficacy of 
ArcCHECK (Sun Nuclear Corp., Melbourne, FL) in quality assurance 
(QA) of Helical TomoTherapy treatment delivery. 
Materials and Methods: Nine clinical Helical TomoTherapy plans of 
different treatment regions and beam widths were randomly selected 
for dosimetric QA measurement using ArcCHECK. A series of test plans 
with cylindrical targets of different dimensions and with different 
treatment beam widths were also made for testing the performance 
of ArcCHECK. Fine grid was used for all test plan optimisation and 
dose calculation. Gamma analysis (passing criteria: 3 % dose 
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difference / 3mm distance to agreement) was used to evaluate the 
difference between the measured and calculated dose distribution of 
the test plans. The threshold dose selected for gamma analysis was 10 
% of the maximum dose. Absolute point dose measurements using 
0.057 cc ionisation chamber (A1SL, Standard Imaging Inc, Middleton, 
WI) placed at the centre of the ArcCHECK with PMMA insert were also 
done for all the clinical and test plans and compared with 
TomoTherapy treatment planning system (TPS) calculation. Inter- and 
intra-fractional consistency of the ArcCHECK measurements was also 
investigated by repeated measurements. 
Results: All absolute point dose measurements showed good 
agreement with TPS calculation and the differences were all within ± 
3%. For clinical Helical TomoTherapy plans, ArcCHECK measurements 
showed excellent results for plans using 2.5 and 5cm beam width, 
with average passing rate of 99.2 and 97.2 %, respectively. The 
average passing rate for clinical plans with 1cm beam width was 82.6 
%. The passing rates of test plans with small cylindrical target of 3cm 
diameter using 1 and 2.5cm beam width were 64.8 and 76.2 % 
respectively. This showed that beam width was not the contributing 
factor for the low passing rate. However, the passing rates of plans 
with cylindrical target of 3 and 8 cm diameter using 1cm beam width 
were 64.8 and 99.1 % respectively. And the analysis of dose profiles 
indicated that measurement resolution was a limiting factor in QA 
measurements of Helical TomoTheapy plans with small target 
dimension in the transverse plane. Excellent inter- and intra-
fractional consistency was found, with average passing rates of 98.5 ± 
0.2 and 97.2 ± 0.1 % respectively. 
Conclusions: ArcCHECK is an efficient and reliable tool for pre-
treatment dosimetric verification of Helical TomoTherapy plans. With 
the use of ArcCHECK, absolute dose comparison can be performed 
with passing rate above 90% using gamma analysis with criteria of 3% / 
3mm. However, attention should be paid when measuring targets with 
small dimensions in transverse plane.  
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Purpose/Objective: LINAC-based radiosurgery is commonly used for 
trigeminal neuralgia treatment. Due to the small size and spherical or 
elliptical geometry of the target, small cones are suitable for this 
technique. Because of the small fields involved in this technique, a 
special care was taken in the measurements and the subsequent 
corrections. 
Materials and Methods: A radiosurgery cone set (Brainlab) of 
diameter 5, 6, 7.5 and 10 mm was modelled for a 6MV linac PRIMUS 
(Siemens). Reference dose was measured using a camera PTW Farmer 
type 30013. Output factor, PDDs and OARs were measured for each 
cone in a PTW water phantom MP3 using a diode detector PTW 60012. 
It was necessary to make a correction in output factors ,because diode 
overestimates response in small fields [1]. Correction is up to6% for 
the cone of 5mm. For commissioning the TPS, a set of verifications 
was performed: accuracy of monitor units calculations, isocentre 
localization, punctual dose with MOSFET, and dose profiles with 
Gafchromics films.  
Results: Output factors are shown in the table. 
 
 
After modelling, we performed several verifications: 
1) Accuracy of monitor unit calculations for several SSD and depths. 
Manual calculation of monitor units performed with measured data 
shows a maximum difference of 1.3%. 
2) Isocentre verification.We used a radiochromic film (Gafchromic 
EBT2) placed in the stereotactic localizer with a pin to locate 
isocentre. After a CT scan was made, pin delineated and used like 
isocentre to deliver the treatment. Isocentre localization was less 
than 0.5mm. (Fig1). 
3) For dose verification we scanned an anthropomorphic Alderson 
Rando phantom head (Fig.2) with a MOSFET detector placed inside. 
We localized the CT scan using iPLan, marked the isocentre at the 
MOSFET and delivered treatment. The dose agreement was for the 10-
mm cone, lesser than 5% (MOSFET uncertainty: 3%). For smaller cones, 
the dose gradient makes very difficult the positioning of the MOSFET, 
hence difference between planned dose and measured dose increases. 
4) Verification with gafchromic EBT2. A film wasplaced at depth of 15 
mm in a water phantom and an arc of 120° was delivered. We 
compared measured datawith TPS calculation using OmniPro® (IBA). A 
good agreement is showed for inplane and crossplane 
comparisons.(Fig3) 
 
  
Conclusions: Due to the difficulty for measuring small fields we 
performed several verifications using different measurement methods 
to commission the modelling of Brainlab cones for trigeminal neuralgia 
in iPlan. The most accurate and reliable method for measuring 
relative dose is Gafchromics films, because it have the best 
resolution. Diodes and MOSFET can be used for output factor 
measurements, but corrections must be taken into account. Results 
are consistent and the first clinical results indicate a favourable 
evolution. 
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Purpose/Objective: Radiochromic EBT3 films are gaining acceptance 
as a valuable dosimetry system. The advantages of these films over 
other dosimetry systems are a low spectral sensitivity, high spatial 
resolution and ease of use. The feasibility to use these EBT3 
GafChromic (GC) films for absolute and relative dosimetry of a 50 kV 
contact therapy system was evaluated. 
Materials and Methods: The half-value layer (HVL) was determined 
for a 3 cm diameter circular applicator usinga soft X-ray parallel-plate 
chamber PTW N23342 (PTW, Freiburg, Germany) based on in-air 
measurement. The HVL of the system is necessary to obtain factors 
converting air-kerma measurements into water-kerma. The absorbed 
dose to water at the surface was determined using the in-air 
calibration method. EBT3 GC films were calibrated at 5 mm depth in a 
solid water phantom (dose range 0-5,5 Gy). The films were scanned 
24h after irradiation with the Epson Expression 10000 XL. Scanvalues 
were acquired using the green and red color channel and converted 
into optical density (OD). These OD were plotted against the dose 
obtained from the ionization chamber to get the calibration curves. 
To acquire the PDD curves, EBT3 films were irradiated in a solid water 
phantom perpendicular or parallel to the beam axis. The films were 
scanned 24h after irradiation and scanvalues were determined for the 
green and red color channel. After conversion of the scanvalues to 
OD, the dose was calculated and the PDD's were plotted.To analyze 
